Alternative splicing: the pledge, the turn, and the prestige: The key role of alternative splicing in human biological systems

Human Genetics

Volumn 136, Issue 9, 2017, Pages 1015-1042

  Gallego Paez, L M ^a   Bordone, M C ^a   Leote, A C ^a   Saraiva Agostinho, N ^a   Ascensao Ferreira M ^a   Barbosa Morais, N L ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; TRANSCRIPTOME; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; DEVELOPMENTAL STAGE; GAMETOGENESIS; GENE REGULATORY NETWORK; HUMAN; IMMUNE SYSTEM; MICROFLORA; MUSCLE TISSUE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SPLICEOSOME; TRANSCRIPTOMICS; GENETICS; METABOLISM;

ALTERNATIVE SPLICING; HUMANS; MICROBIOTA; RNA, MESSENGER;

EID: 85016946993     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-017-1790-y     Document Type: Review

References (322)

1. Aartsma-Rus A, Krieg AM (2016) FDA approves eteplirsen for duchenne muscular dystrophy: the next chapter in the eteplirsen saga. Nucleic Acid Ther. doi:10.1089/nat.2016.0657
2. Abbas AK, Lichtman AHH, Pillai S (2014) Cellular and molecular immunology. Elsevier Health Sciences
3. Ahmadi Rastegar D, Sharifi Tabar M, Alikhani M et al (2015) Isoform-level gene expression profiles of human Y chromosome azoospermia factor genes and their X chromosome paralogs in the testicular tissue of non-obstructive azoospermia patients. J Proteome Res 14:3595–3605
4. E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78. MBio 6:e02068
5. Albert BJ, McPherson PA, O’Brien K et al (2009) Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells. Mol Cancer Ther 8:2308–2318
6. Alsafadi S, Houy A, Battistella A et al (2016) Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. Nat Commun 7:10615
7. Anczuków O, Rosenberg AZ, Akerman M et al (2012) The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol 19:220–228
8. Anczuków O, Akerman M, Cléry A et al (2015) SRSF1-Regulated Alternative Splicing in Breast Cancer. Mol Cell 60:105–117
9. Anderson MS, Venanzi ES, Klein L et al (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395–1401
10. Aprianto R, Slager J, Holsappel S, Veening J-W (2016) Time-resolved dual RNA-seq reveals extensive rewiring of lung epithelial and pneumococcal transcriptomes during early infection. Genome Biol 17:198
11. Arch R, Wirth K, Hofmann M et al (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682–685
12. Ashwal-Fluss R, Meyer M, Pamudurti NR et al (2014) circRNA biogenesis competes with pre-mRNA splicing. Mol Cell 56:55–66
13. Baaten BJG, Li C-R, Deiro MF et al (2010) CD44 regulates survival and memory development in Th1 cells. Immunity 32:104–115
14. Bao J, Tang C, Li J et al (2014) RAN-binding protein 9 is involved in alternative splicing and is critical for male germ cell development and male fertility. PLoS Genet 10:e1004825
15. Barash Y, Calarco JA, Gao W et al (2010) Deciphering the splicing code. Nature 465:53–59
16. Barbosa-Morais NL, Irimia M, Pan Q et al (2012) The evolutionary landscape of alternative splicing in vertebrate species. Science 338:1587–1593
17. Bates DO, Morris JC, Oltean S, Donaldson LF (2017) Pharmacology of Modulators of Alternative Splicing. Pharmacol Rev 69:63–79
18. Bauman J, Jearawiriyapaisarn N, Kole R (2009) Therapeutic potential of splice-switching oligonucleotides. Oligonucleotides 19:1–13
19. Benabdillah R, Mota LJ, Lützelschwab S et al (2004) Identification of a nuclear targeting signal in YopM from Yersinia spp. Microb Pathog 36:247–261
20. Benson MJ, Aijö T, Chang X et al (2012) Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells. Proc Natl Acad Sci USA 109:16252–16257
21. Berger A, Maire S, Gaillard M-C et al (2016) mRNAtrans-splicing in gene therapy for genetic diseases. Wiley Interdiscip Rev RNA 7:487–498
22. Berget SM, Moore C, Sharp PA (1977) Spliced segments at the 5′ terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci USA 74:3171–3175
23. Berkovits BD, Wang L, Guarnieri P, Wolgemuth DJ (2012) The testis-specific double bromodomain-containing protein BRDT forms a complex with multiple spliceosome components and is required for mRNA splicing and 3′-UTR truncation in round spermatids. Nucleic Acids Res 40:7162–7175
24. Berto S, Usui N, Konopka G, Fogel BL (2016) ELAVL2-regulated transcriptional and splicing networks in human neurons link neurodevelopment and autism. Hum Mol Genet 25:2451–2464
25. Beverley PC, Merkenschlager M, Terry L (1988) Phenotypic diversity of the CD45 antigen and its relationship to function. Immunol Suppl 1:3–5
26. Beverley PC, Daser A, Michie CA, Wallace DL (1992) Functional subsets of T cells defined by isoforms of CD45. Biochem Soc Trans 20:184–187
27. Bierne H, Cossart P (2012) When bacteria target the nucleus: the emerging family of nucleomodulins. Cell Microbiol 14:622–633
28. Blencowe BJ (2006) Alternative splicing: new insights from global analyses. Cell 126:37–47
29. Boise LH, González-García M, Postema CE et al (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597–608
30. Bonomi S, Gallo S, Catillo M et al (2013) Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy. Int J Cell Biol 2013:962038
31. Boutz PL, Stoilov P, Li Q et al (2007) A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 21:1636–1652
32. Brody E, Abelson J (1985) The “spliceosome”: yeast pre-messenger RNA associates with a 40S complex in a splicing-dependent reaction. Science 228:963–967
33. Brooks AN, Choi PS, de Waal L et al (2014) A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PLoS One 9:e87361
34. Bryant HE, Wadd SE, Lamond AI et al (2001) Herpes simplex virus IE63 (ICP27) protein interacts with spliceosome-associated protein 145 and inhibits splicing prior to the first catalytic step. J Virol 75:4376–4385
35. Butcher SE, Brow DA (2005) Towards understanding the catalytic core structure of the spliceosome. Biochem Soc Trans 33:447–449
36. Calarco JA, Superina S, O’Hanlon D et al (2009) Regulation of vertebrate nervous system alternative splicing and development by an SR-related protein. Cell 138:898–910
37. Carpenter S, Ricci EP, Mercier BC et al (2014) Post-transcriptional regulation of gene expression in innate immunity. Nat Rev Immunol 14:361–376
38. Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285–298
39. Chabot B, Shkreta L (2016) Defective control of pre-messenger RNA splicing in human disease. J Cell Biol 212:13–27
40. Charlet-B N, Logan P, Singh G, Cooper TA (2002) Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol Cell 9:649–658
41. Chee AV, Lopez P, Pandolfi PP, Roizman B (2003) Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol 77:7101–7105
42. Chen L, Bush SJ, Tovar-Corona JM et al (2014) Correcting for differential transcript coverage reveals a strong relationship between alternative splicing and organism complexity. Mol Biol Evol 31:1402–1413
43. Cheng J, Zhou T, Liu C et al (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759–1762
44. Cheng H, Zheng M, Peter AK et al (2011) Selective deletion of long but not short Cypher isoforms leads to late-onset dilated cardiomyopathy. Hum Mol Genet 20:1751–1762
45. Ching RW, Dellaire G, Eskiw CH, Bazett-Jones DP (2005) PML bodies: a meeting place for genomic loci? J Cell Sci 118:847–854
46. Chiou N-T, Lynch KW (2014) Mechanisms of spliceosomal assembly. Methods Mol Biol 1126:35–43
47. Chow LT, Gelinas RE, Broker TR, Roberts RJ (1977) An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell 12:1–8
48. Clower CV, Chatterjee D, Wang Z et al (2010) The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci USA 107:1894–1899
49. Coelho MB, Smith CWJ (2014) Regulation of alternative pre-mRNA splicing. Methods Mol Biol 1126:55–82
50. Conboy JG (2016) Developmental regulation of RNA processing by Rbfox proteins. Wiley Interdiscip Rev RNA. doi:10.1002/wrna.1398
51. Cookson MR (2017) RNA-binding proteins implicated in neurodegenerative diseases. Wiley Interdiscip Rev RNA. doi:10.1002/wrna.1397
52. Danan-Gotthold M, Golan-Gerstl R, Eisenberg E et al (2015) Identification of recurrent regulated alternative splicing events across human solid tumors. Nucleic Acids Res 43:5130–5144
53. Danan-Gotthold M, Guyon C, Giraud M et al (2016) Extensive RNA editing and splicing increase immune self-representation diversity in medullary thymic epithelial cells. Genome Biol 17:219
54. David CJ, Manley JL (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24:2343–2364
55. David CJ, Chen M, Assanah M et al (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463:364–368
56. De Conti L, Baralle M, Buratti E (2013) Exon and intron definition in pre-mRNA splicing. Wiley Interdiscip Rev RNA. doi:10.1002/wrna.1140
57. DeGrendele HC, Kosfiszer M, Estess P, Siegelman MH (1997) CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 159:2549–2553
58. Dehm SM, Tindall DJ (2011) Alternatively spliced androgen receptor variants. Endocr Relat Cancer 18:R183–R196
59. DeMicco A, Naradikian MS, Sindhava VJ et al (2015) B cell-intrinsic expression of the HuR RNA-binding protein is required for the T cell-dependent immune response in vivo. J Immunol 195:3449–3462
60. Derbinski J, Schulte A, Kyewski B, Klein L (2001) Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2:1032–1039
61. Diaz-Muñoz MD, Bell SE, Fairfax K et al (2015) The RNA-binding protein HuR is essential for the B cell antibody response. Nat Immunol 16:415–425
62. Domdey H, Apostol B, Lin RJ et al (1984) Lariat structures are in vivo intermediates in yeast pre-mRNA splicing. Cell 39:611–621
63. Dominguez D, Tsai Y-H, Weatheritt R et al (2016) An extensive program of periodic alternative splicing linked to cell cycle progression. Elife. doi:10.7554/eLife.10288
64. Douglas AGL, Wood MJA (2011) RNA splicing: disease and therapy. Brief Funct Genomics 10:151–164
65. Dredge BK, Jensen KB (2011) NeuN/Rbfox3 nuclear and cytoplasmic isoforms differentially regulate alternative splicing and nonsense-mediated decay of Rbfox2. PLoS One 6:e21585
66. Droin N, Bichat F, Rébé C et al (2001) Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells. Blood 97:1835–1844
67. Du L, Kayali R, Bertoni C et al (2011) Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum. Hum Mol Genet 20:3151–3160
68. Dvinge H, Bradley RK (2015) Widespread intron retention diversifies most cancer transcriptomes. Genome Med 7:45
69. Dvinge H, Kim E, Abdel-Wahab O, Bradley RK (2016) RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer 16:413–430
70. Early P, Huang H, Davis M et al (1980a) An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell 19:981–992
71. Early P, Rogers J, Davis M et al (1980b) Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways. Cell 20:313–319
72. Elliott DJ, Grellscheid SN (2006) Alternative RNA splicing regulation in the testis. Reproduction 132:811–819
73. Eskens FALM, Ramos FJ, Burger H et al (2013) Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors. Clin Cancer Res 19:6296–6304
74. Evsyukova I, Somarelli JA, Gregory SG, Garcia-Blanco MA (2010) Alternative splicing in multiple sclerosis and other autoimmune diseases. RNA Biol 7:462–473
75. Fardilha M, Wu W, Sá R et al (2004) Alternatively spliced protein variants as potential therapeutic targets for male infertility and contraception. Ann N Y Acad Sci 1030:468–478
76. Fletcher S, Bellgard MI, Price L et al (2017) Translational development of splice-modifying antisense oligomers. Expert Opin Biol Ther 17:15–30
77. Foulkes NS, Mellström B, Benusiglio E, Sassone-Corsi P (1992) Developmental switch of CREM function during spermatogenesis: from antagonist to activator. Nature 355:80–84
78. Francavilla C, Rigbolt KTG, Emdal KB et al (2013) Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs. Mol Cell 51:707–722
79. Fu X-D, Ares M Jr (2014) Context-dependent control of alternative splicing by RNA-binding proteins. Nat Rev Genet 15:689–701
80. Fukuhara T, Hosoya T, Shimizu S et al (2006) Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc Natl Acad Sci USA 103:11329–11333
81. Gallinaro H, Lazar E, Jacob M et al (1981) Small RNAs in HnRNP fibrils and their possible function in splicing. Mol Biol Rep 7:31–39
82. Gao C, Ren S, Lee J-H et al (2016) RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure. J Clin Invest 126:195–206
83. Garcia-Blanco MA, Baraniak AP, Lasda EL (2004) Alternative splicing in disease and therapy. Nat Biotechnol 22:535–546
84. Gehman LT, Meera P, Stoilov P et al (2012) The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. Genes Dev 26:445–460
85. George CH, Rogers SA, Bertrand BMA et al (2007) Alternative splicing of ryanodine receptors modulates cardiomyocyte Ca2 + signaling and susceptibility to apoptosis. Circ Res 100:874–883
86. Ghigna C, Giordano S, Shen H et al (2005) Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol Cell 20:881–890
87. Gigli M, Begay RL, Morea G et al (2016) A review of the giant protein titin in clinical molecular diagnostics of cardiomyopathies. Front Cardiovasc Med 3:21
88. Gilbert W (1978) Why genes in pieces? Nature 271:501
89. Giudice J, Xia Z, Wang ET et al (2014) Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. Nat Commun 5:3603
90. Giudice J, Loehr JA, Rodney GG, Cooper TA (2016) Alternative splicing of four trafficking genes regulates myofiber structure and skeletal muscle physiology. Cell Rep 17:1923–1933
91. Goers ES, Purcell J, Voelker RB et al (2010) MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res 38:2467–2484
92. Gonçalves V, Henriques AFA, Henriques A et al (2014) Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells. RNA 20:474–482
93. Goo Y-H, Cooper TA (2009) CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA. Nucleic Acids Res 37:4275–4286
94. Goren A, Ram O, Amit M et al (2006) Comparative analysis identifies exonic splicing regulatory sequences—the complex definition of enhancers and silencers. Mol Cell 22:769–781
95. Graham SV, Faizo AAA (2016) Control of human papillomavirus gene expression by alternative splicing. Virus Res. doi:10.1016/j.virusres.2016.11.016
96. Grosso AR, Gomes AQ, Barbosa-Morais NL et al (2008) Tissue-specific splicing factor gene expression signatures. Nucleic Acids Res 36:4823–4832
97. Grosso AR, Leite AP, Carvalho S et al (2015) Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma. Elife. doi:10.7554/eLife.09214
98. Gueroussov S, Gonatopoulos-Pournatzis T, Irimia M et al (2015) An alternative splicing event amplifies evolutionary differences between vertebrates. Science 349:868–873
99. Gunning PW, Schevzov G, Kee AJ, Hardeman EC (2005) Tropomyosin isoforms: divining rods for actin cytoskeleton function. Trends Cell Biol 15:333–341
100. Guo W, Schafer S, Greaser ML et al (2012) RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med 18:766–773
101. Guo J, Jia J, Jia R (2015) PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells. Sci Rep 5:14548
102. Hafner M, Landthaler M, Burger L et al (2010) PAR-CliP: a method to identify transcriptome-wide the binding sites of RNA binding proteins. J Vis Exp. doi:10.3791/2034
103. Hamada N, Ito H, Iwamoto I et al (2015) Role of the cytoplasmic isoform of RBFOX1/A2BP1 in establishing the architecture of the developing cerebral cortex. Mol Autism 6:56
104. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
105. Haraga A, Miller SI (2003) A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits Nf-B-dependent gene expression. Infect Immun 71:4052–4058
106. Harbour JW, Roberson EDO, Anbunathan H et al (2013) Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet 45:133–135
107. Häsler J, Strub K (2006) Alu elements as regulators of gene expression. Nucleic Acids Res 34:5491–5497
108. Havens MA, Hastings ML (2016) Splice-switching antisense oligonucleotides as therapeutic drugs. Nucleic Acids Res 44:6549–6563
109. Havens MA, Duelli DM, Hastings ML (2013) Targeting RNA splicing for disease therapy. Wiley Interdiscip Rev RNA. doi:10.1002/wrna.1158
110. Heinzen EL, Yoon W, Weale ME et al (2007) Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer’s disease. Genome Biol 8:R32
111. Hermann T, Westhof E (1998) RNA as a drug target: chemical, modelling, and evolutionary tools. Curr Opin Biotechnol 9:66–73
112. Hernandez-Lopez HR, Graham SV (2012) Alternative splicing in human tumour viruses: a therapeutic target? Biochem J 445:145–156
113. Ho TH, Charlet-B N, Poulos MG et al (2004) Muscleblind proteins regulate alternative splicing. EMBO J 23:3103–3112
114. Holland C, Schmid M, Zimny-Arndt U et al (2011) Quantitative phosphoproteomics reveals link between Helicobacter pylori infection and RNA splicing modulation in host cells. Proteomics 11:2798–2811
115. House RP, Talwar S, Hazard ES et al (2015) RNA-binding protein CELF1 promotes tumor growth and alters gene expression in oral squamous cell carcinoma. Oncotarget 6:43620–43634
116. Hsu TY-T, Simon LM, Neill NJ et al (2015) The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature 525:384–388
117. Hu B, Li X, Huo Y et al (2016) Cellular responses to HSV-1 infection are linked to specific types of alterations in the host transcriptome. Sci Rep 6:28075
118. Hughes DP, Crispe IN (1995) A naturally occurring soluble isoform of murine Fas generated by alternative splicing. J Exp Med 182:1395–1401
119. Iijima T, Iijima Y, Witte H, Scheiffele P (2014) Neuronal cell type–specific alternative splicing is regulated by the KH domain protein SLM1. J Cell Biol 204:331–342
120. Iijima T, Takatoshi I, Chiharu H, Yoko I (2016) Spatio-temporal regulations and functions of neuronal alternative RNA splicing in developing and adult brains. Neurosci Res 109:1–8
121. Ip JY, Tong A, Pan Q et al (2007) Global analysis of alternative splicing during T-cell activation. RNA 13:563–572
122. Irimia M, Weatheritt RJ, Ellis JD et al (2014) A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell 159:1511–1523
123. Ivanov A, Memczak S, Wyler E et al (2015) Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep 10:170–177
124. Iwamori N, Tominaga K, Sato T et al (2016) MRG15 is required for pre-mRNA splicing and spermatogenesis. Proc Natl Acad Sci USA 113:E5408–E5415
125. Izquierdo JM, Valcárcel J (2007) Fas-activated serine/threonine kinase (FAST K) synergizes with TIA-1/TIAR proteins to regulate Fas alternative splicing. J Biol Chem 282:1539–1543
126. Izquierdo JM, Majós N, Bonnal S et al (2005) Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell 19:475–484
127. Jeck WR, Sorrentino JA, Wang K et al (2013) Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19:141–157
128. Jensen MA, Wilkinson JE, Krainer AR (2014) Splicing factor SRSF6 promotes hyperplasia of sensitized skin. Nat Struct Mol Biol 21:189–197
129. Jia R (2010) SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int J Biol Sci 6:806–826
130. Jung H, Lee D, Lee J et al (2015) Intron retention is a widespread mechanism of tumor-suppressor inactivation. Nat Genet 47:1242–1248
131. Kalsotra A, Xiao X, Ward AJ et al (2008) A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci USA 105:20333–20338
132. Kanemori Y, Ryu J-H, Sudo M et al (2013) Two functional forms of ACRBP/sp32 are produced by pre-mRNA alternative splicing in the mouse. Biol Reprod 88:105
133. Kanemori Y, Koga Y, Sudo M et al (2016) Biogenesis of sperm acrosome is regulated by pre-mRNA alternative splicing of Acrbp in the mouse. Proc Natl Acad Sci USA 113:E3696–E3705
134. Karakaya C, Guzeloglu-Kayisli O, Hobbs RJ et al (2014) Follicle-stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSH. Mol Hum Reprod 20:630–643
135. Karni R, de Stanchina E, Lowe SW et al (2007) The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 14:185–193
136. Kelemen O, Convertini P, Zhang Z et al (2013) Function of alternative splicing. Gene 514:1–30
137. Keppetipola N, Sharma S, Li Q, Black DL (2012) Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2. Crit Rev Biochem Mol Biol 47:360–378
138. Kim KK, Nam J, Mukouyama Y-S, Kawamoto S (2013) Rbfox3-regulated alternative splicing of numb promotes neuronal differentiation during development. J Cell Biol 200:443–458
139. Kim J-H, Baddoo MC, Park EY et al (2016) SON and its alternatively spliced isoforms control MLL complex-mediated H3K4me3 and transcription of leukemia-associated genes. Mol Cell 61:859–873
140. Klein L, Klugmann M, Nave KA et al (2000) Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med 6:56–61
141. Klinck R, Fourrier A, Thibault P et al (2014) RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1. PLoS ONE 9:e107324
142. Koh CM, Bezzi M, Low DHP et al (2015) MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis. Nature 523:96–100
143. Kozyrev SV, Abelson A-K, Wojcik J et al (2008) Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 40:211–216
144. Krainer AR, Maniatis T (1985) Multiple factors including the small nuclear ribonucleoproteins U1 and U2 are necessary for Pre-mRNA splicing in vitro. Cell 42:725–736
145. Krainer AR, Conway GC, Kozak D (1990) Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. Genes Dev 4:1158–1171
146. Krämer A, Keller W (1985) Purification of a protein required for the splicing of pre-mRNA and its separation from the lariat debranching enzyme. EMBO J 4:3571–3581
147. Kress C, Gautier-Courteille C, Osborne HB et al (2007) Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol Cell Biol 27:1146–1157
148. Krummel MF, Allison JP (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 182:459–465
149. Kuhn AN, van Santen MA, Schwienhorst A et al (2009) Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation. RNA 15:153–175
150. Kumar D, Kashyap MK, La Clair JJ et al (2016) Selectivity in small molecule splicing modulation. ACS Chem Biol 11:2716–2723
151. La Cognata V, D’Agata V, Cavalcanti F, Cavallaro S (2015) Splicing: is there an alternative contribution to Parkinson’s disease? Neurogenetics 16:245–263
152. Ladomery M (2013) Aberrant alternative splicing is another hallmark of cancer. Int J Cell Biol 2013:463786
153. Lambrot R, Jones S, Saint-Phar S, Kimmins S (2012) Specialized distribution of the histone methyltransferase Ezh2 in the nuclear apical region of round spermatids and its interaction with the histone variant H1t2. J Androl 33:1058–1066
154. Lamson G (1984) Changes in J chain and mu chain RNA expression as a function of B cell differentiation. J Exp Med 160:877–892
155. Lara-Pezzi E, Gómez-Salinero J, Gatto A, García-Pavía P (2013) The alternative heart: impact of alternative splicing in heart disease. J Cardiovasc Transl Res 6:945–955
156. Lara-Pezzi E, Desco M, Gatto A, Gómez-Gaviro MV (2016) Neurogenesis: regulation by alternative splicing and related posttranscriptional processes. Neuroscientist. doi:10.1177/1073858416678604
157. Lee JE, Cooper TA (2009) Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 37:1281–1286
158. Lee J-A, Damianov A, Lin C-H et al (2016) Cytoplasmic Rbfox1 regulates the expression of synaptic and autism-related genes. Neuron 89:113–128
159. Leggere JC, Saito Y, Darnell RB et al (2016) NOVA regulates Dcc alternative splicing during neuronal migration and axon guidance in the spinal cord. Elife. doi:10.7554/eLife.14264
160. Lerner MR, Boyle JA, Mount SM et al (1980) Are snRNPs involved in splicing? Nature 283:220–224
161. Leu S, Lin Y-M, Wu C-H, Ouyang P (2012) Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD. J Cell Sci 125:3164–3172
162. Lev-Maor G, Ram O, Kim E et al (2008) Intronic Alus influence alternative splicing. PLoS Genet 4:e1000204
163. Li Q, Zheng S, Han A et al (2014) The splicing regulator PTBP2 controls a program of embryonic splicing required for neuronal maturation. Elife 3:e01201
164. Licatalosi DD, Mele A, Fak JJ et al (2008) HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456:464–469
165. Licatalosi DD, Yano M, Fak JJ et al (2012) Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. Genes Dev 26:1626–1642
166. Lin Y-S, Wang H-Y, Huang D-F et al (2016) Neuronal Splicing Regulator RBFOX3 (NeuN) Regulates Adult Hippocampal Neurogenesis and Synaptogenesis. PLoS One 11:e0164164
167. Linares AJ, Lin C-H, Damianov A et al (2015) The splicing regulator PTBP1 controls the activity of the transcription factor Pbx1 during neuronal differentiation. Elife 4:e09268
168. Lipscombe D, Diane L (2005) Neuronal proteins custom designed by alternative splicing. Curr Opin Neurobiol 15:358–363
169. Liu C, Tucker P, Mushinski J, Blattner F (1980) Mapping of heavy chain genes for mouse immunoglobulins M and D. Science 209:1348–1353
170. Liu W, Wang F, Xu Q et al (2017) BCAS2 is involved in alternative mRNA splicing in spermatogonia and the transition to meiosis. Nat Commun 8:14182
171. Llorian M, Smith CWJ (2011) Decoding muscle alternative splicing. Curr Opin Genet Dev 21:380–387
172. Love EJ, Hayden JE, Rohn TT (2015) Alternative splicing in Alzheimer’s disease. J Parkinsons Dis Alzheimers Dis. doi:10.13188/2376-922X.1000010
173. Luco RF, Pan Q, Tominaga K et al (2010) Regulation of alternative splicing by histone modifications. Science 327:996–1000
174. Lynch KW, Weiss A (2001) A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J Biol Chem 276:24341–24347
175. Maatz H, Jens M, Liss M et al (2014) RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J Clin Invest 124:3419–3430
176. Magistrelli G, Jeannin P, Herbault N et al (1999) A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 29:3596–3602
177. Malamitsi-Puchner A, Sarandakou A, Baka SG et al (2001) Concentrations of angiogenic factors in follicular fluid and oocyte-cumulus complex culture medium from women undergoing in vitro fertilization: association with oocyte maturity and fertilization. Fertil Steril 76:98–101
178. Mallory MJ, Jackson J, Weber B et al (2011) Signal- and development-dependent alternative splicing of LEF1 in T cells is controlled by CELF2. Mol Cell Biol 31:2184–2195
179. Mankodi A, Takahashi MP, Jiang H et al (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10:35–44
180. Martin M, Maßhöfer L, Temming P et al (2013) Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet 45:933–936
181. Martinez NM, Pan Q, Cole BS et al (2012) Alternative splicing networks regulated by signaling in human T cells. RNA 18:1029–1040
182. Martínez-Montiel N, Rosas-Murrieta NH, Martínez-Montiel M et al (2016) Microbial and natural metabolites that inhibit splicing: a powerful alternative for cancer treatment. Biomed Res Int 2016:3681094
183. Matera AG, Gregory Matera A, Zefeng W (2014) A day in the life of the spliceosome. Nat Rev Mol Cell Biol 15:294
184. Mayya V, Lundgren DH, Hwang S-I et al (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2:ra46
185. McClorey G, Wood MJ (2015) An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies. Curr Opin Pharmacol 24:52–58
186. McFarlane M, MacDonald AI, Stevenson A, Graham SV (2015) Human papillomavirus 16 oncoprotein expression is controlled by the cellular splicing factor SRSF2 (SC35). J Virol 89:5276–5287
187. Meininger I, Isabel M, Griesbach RA et al (2016) Alternative splicing of MALT1 controls signalling and activation of CD4 T cells. Nat Commun 7:11292
188. Melchers F, Andersson J (1973) Synthesis, surface deposition and secretion of immunoglobulin M in bone marrow-derived lymphocytes before and after mitogenic stimulation. Immunol Rev 14:76–130
189. Melton AA, Jackson J, Wang J, Lynch KW (2007) Combinatorial control of signal-induced exon repression by hnRNP L and PSF. Mol Cell Biol 27:6972–6984
190. Memon D, Dawson K, Smowton CSF et al (2016) Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response. NPJ Genom Med 1:16020
191. Merkenschlager M, Beverley PC (1989) Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTLp selectively express CD45RO (UCHL1). Int Immunol 1:450–459
192. Merkin J, Russell C, Chen P, Burge CB (2012) Evolutionary dynamics of gene and isoform regulation in mammalian tissues. Science 338:1593–1599
193. Miller TM, Pestronk A, David W et al (2013) An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol 12:435–442
194. Mills JD, Michal J (2012) Alternative splicing of mRNA in the molecular pathology of neurodegenerative diseases. Neurobiol Aging 33:1012.e11–1012.e24
195. Minnich M, Tagoh H, Bönelt P et al (2016) Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation. Nat Immunol 17:331–343
196. Moore MJ, Wang Q, Kennedy CJ, Silver PA (2010) An alternative splicing network links cell-cycle control to apoptosis. Cell 142:625–636
197. Motta-Mena LB, Heyd F, Lynch KW (2010) Context-dependent regulatory mechanism of the splicing factor hnRNP L. Mol Cell 37:223–234
198. Moulton VR, Tsokos GC (2010) Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex. J Biol Chem 285:12490–12496
199. Muhlemann O, Yue B-G, Petersen-Mahrt S, Akusjarvi G (2000) A novel type of splicing enhancer regulating adenovirus pre-mRNA splicing. Mol Cell Biol 20:2317–2325
200. Muise AM, Walters T, Wine E et al (2007) Protein-tyrosine phosphatase sigma is associated with ulcerative colitis. Curr Biol 17:1212–1218
201. Nagueh SF, Shah G, Wu Y et al (2004) Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 110:155–162
202. Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function and association with the malignant process. In: Advances in Cancer Research. pp 241–319
203. Ng B, Yang F, Huston DP et al (2004) Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes. J Allergy Clin Immunol 114:1463–1470
204. Nojima T, Oshiro-Ideue T, Nakanoya H et al (2009) Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing. Nucleic Acids Res 37:6515–6527
205. Nolan J, Nolan C (2006) The Prestige
206. Norris AD, Calarco JA (2012) Emerging roles of alternative Pre-mRNA splicing regulation in neuronal development and function. Front Neurosci 6:122
207. Nowak DG, Amin EM, Rennel ES et al (2010) Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. J Biol Chem 285:5532–5540
208. Nussbacher JK, Batra R, Lagier-Tourenne C, Yeo GW (2015) RNA-binding proteins in neurodegeneration: seq and you shall receive. Trends Neurosci 38:226–236
209. O’Bryan MK, Clark BJ, McLaughlin EA et al (2013) RBM5 is a male germ cell splicing factor and is required for spermatid differentiation and male fertility. PLoS Genet 9:e1003628
210. Oaks MK, Hallett KM, Penwell RT et al (2000) A native soluble form of CTLA-4. Cell Immunol 201:144–153
211. Oberdoerffer S, Moita LF, Neems D et al (2008) Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science 321:686–691
212. Ohshima Y, Itoh M, Okada N, Miyata T (1981) Novel models for RNA splicing that involve a small nuclear RNA. Proc Natl Acad Sci 78:4471–4474
213. Okuda J, Toyotome T, Kataoka N et al (2005) Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses. Biochem Biophys Res Commun 333:531–539
214. Olshavsky NA, Comstock CES, Schiewer MJ et al (2010) Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene. Cancer Res 70:3975–3984
215. Oltean S, Bates DO (2014) Hallmarks of alternative splicing in cancer. Oncogene 33:5311–5318
216. Onouchi Y, Gunji T, Burns JC et al (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35–42
217. Opitz CA, Leake MC, Makarenko I et al (2004) Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circ Res 94:967–975
218. Osman EY, Washington CW 3rd, Kaifer KA et al (2016) Optimization of morpholino antisense oligonucleotides targeting the intronic repressor element1 in spinal muscular atrophy. Mol Ther 24:1592–1601
219. Padgett RA, Konarska MM, Grabowski PJ et al (1984) Lariat RNA’s as intermediates and products in the splicing of messenger RNA precursors. Science 225:898–903
220. Paronetto MP, Zalfa F, Botti F et al (2006) The nuclear RNA-binding protein Sam68 translocates to the cytoplasm and associates with the polysomes in mouse spermatocytes. Mol Biol Cell 17:14–24
221. Paronetto MP, Passacantilli I, Sette C (2016) Alternative splicing and cell survival: from tissue homeostasis to disease. Cell Death Differ 23:1919–1929
222. Pawellek A, McElroy S, Samatov T et al (2014) Identification of small molecule inhibitors of pre-mRNA splicing. J Biol Chem 289:34683–34698
223. Peri A, Serio M (2014) The CREM system in human spermatogenesis. J Endocrinol Invest 23:578–583
224. Pintucci G, Moscatelli D, Saponara F et al (2002) Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J 16:598–600
225. Pistoni M, Ghigna C, Gabellini D (2010) Alternative splicing and muscular dystrophy. RNA Biol 7:441–452
226. Polymenidou M, Lagier-Tourenne C, Hutt KR et al (2012) Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res 1462:3–15
227. Preussner M, Schreiner S, Hung L-H et al (2012) HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing. Nucleic Acids Res 40:5666–5678
228. Qi Y, Yu J, Han W et al (2016) A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation. Nat Commun 7:ncomms11840
229. Raj B, O’Hanlon D, Vessey JP et al (2011) Cross-regulation between an alternative splicing activator and a transcription repressor controls neurogenesis. Mol Cell 43:843–850
230. Raj B, Irimia M, Braunschweig U et al (2014) A global regulatory mechanism for activating an exon network required for neurogenesis. Mol Cell 56:90–103
231. Raj B, Bushra R, Blencowe BJ (2015) Alternative Splicing in the Mammalian Nervous System: recent Insights into Mechanisms and Functional Roles. Neuron 87:14–27
232. Ramalingam S, Ramamoorthy P, Subramaniam D, Anant S (2012) Reduced expression of RNA binding protein CELF2, a putative tumor suppressor gene in colon cancer. Immunogastroenterology 1:27–33
233. Reed R, Maniatis T (1985) Intron sequences involved in lariat formation during pre-mRNA splicing. Cell 41:95–105
234. Rogers J (1980) Two mRNAs with different 3′ ends encode membrane-bound and secreted forms of immunoglobulin μ chain. Cell 20:303–312
235. Rosani U, Varotto L, Domeneghetti S et al (2015) Dual analysis of host and pathogen transcriptomes in ostreid herpesvirus 1-positive Crassostrea gigas. Environ Microbiol 17:4200–4212
236. Rosenberger S, De-Castro Arce J, Langbein L et al (2010) Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation. Proc Natl Acad Sci USA 107:7006–7011
237. Rosenfeld MG, Amara SG, Roos BA et al (1981) Altered expression of the calcitonin gene associated with RNA polymorphism. Nature 290:63–65
238. Rosenfeld MG, Lin CR, Amara SG et al (1982) Calcitonin mRNA polymorphism: peptide switching associated with alternative RNA splicing events. Proc Natl Acad Sci USA 79:1717–1721
239. Rossbach O, Hung L-H, Khrameeva E et al (2014) Crosslinking-immunoprecipitation (iCLIP) analysis reveals global regulatory roles of hnRNP L. RNA Biol 11:146–155
240. Rothrock CR, House AE, Lynch KW (2005) HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J 24:2792–2802
241. Rueter SM, Dawson TR, Emeson RB (1999) Regulation of alternative splicing by RNA editing. Nature 399:75–80
242. Runfola V, Sebastian S, Dilworth FJ, Gabellini D (2015) Rbfox proteins regulate tissue-specific alternative splicing of Mef2D required for muscle differentiation. J Cell Sci 128:631–637
243. Ruskin B, Krainer AR, Maniatis T, Green MR (1984) Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38:317–331
244. Ruskin B, Zamore PD, Green MR (1988) A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell 52:207–219
245. Ryan M, Wong WC, Brown R et al (2016) TCGASpliceSeq a compendium of alternative mRNA splicing in cancer. Nucleic Acids Res 44:D1018–D1022
246. Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC (1996) BIN1 is a novel MYC–interacting protein with features of a tumour suppressor. Nat Genet 14:69–77
247. Salton M, Misteli T (2016) Small molecule modulators of Pre-mRNA splicing in cancer therapy. Trends Mol Med 22:28–37
248. Sammeth M, Foissac S, Guigó R (2008) A general definition and nomenclature for alternative splicing events. PLoS Comput Biol 4:e1000147
249. Sandri-Goldin RM, Hibbard MK (1996) The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-Sm antiserum, and the C terminus appears to be required for this interaction. J Virol 70:108–118
250. Saucedo L, Buffa GN, Rosso M et al (2015) Fibroblast Growth Factor Receptors (FGFRs) in Human Sperm: expression, Functionality and Involvement in Motility Regulation. PLoS ONE 10:e0127297
251. Savkur RS, Philips AV, Cooper TA (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29:40–47
252. Schmid R, Grellscheid SN, Ehrmann I et al (2013) The splicing landscape is globally reprogrammed during male meiosis. Nucleic Acids Res 41:10170–10184
253. Sciabica KS, Dai QJ, Sandri-Goldin RM (2003) ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J 22:1608–1619
254. Scotti MM, Swanson MS (2016) RNA mis-splicing in disease. Nat Rev Genet 17:19–32
255. Sebestyén E, Zawisza M, Eyras E (2015) Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer. Nucleic Acids Res 43:1345–1356
256. Sebestyén E, Singh B, Miñana B et al (2016) Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks. Genome Res 26:732–744
257. Sedlackova L, Rice SA (2008) Herpes simplex virus type 1 immediate-early protein ICP27 is required for efficient incorporation of ICP0 and ICP4 into virions. J Virol 82:268–277
258. Seeley RR, Stephens TD, Tate P (2006) Anatomy and physiology. McGraw-Hill
259. Seol DW, Billiar TR (1999) A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J Biol Chem 274:2072–2076
260. Shaffer AL, Lin KI, Kuo TC et al (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51–62
261. Shen S, Wang Y, Wang C et al (2016) SURVIV for survival analysis of mRNA isoform variation. Nat Commun 7:11548
262. Shultz JC, Goehe RW, Murudkar CS et al (2011) SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Mol Cancer Res 9:889–900
263. Simon JM, Hacker KE, Singh D et al (2014) Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects. Genome Res 24:241–250
264. Singh NN, Shishimorova M, Cao LC et al (2009) A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy. RNA Biol 6:341–350
265. Solana J, Irimia M, Ayoub S et al (2016) Conserved functional antagonism of CELF and MBNL proteins controls stem cell-specific alternative splicing in planarians. Elife. doi:10.7554/eLife.16797
266. Spellman R, Llorian M, Smith CWJ (2007) Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol Cell 27:420–434
267. Sperling R (2016) The nuts and bolts of the endogenous spliceosome. Wiley Interdiscip Rev RNA. doi:10.1002/wrna.1377
268. Squire JM (2016) Muscle contraction: Sliding filament history, sarcomere dynamics and the two Huxleys. Global Cardiol Sci Pract. doi:10.21542/gcsp.2016.11
269. Stenson PD, Mort M, Ball EV et al (2009) The human gene mutation database: 2008 update. Genome Med 1:13
270. Stiewe T, Pützer BM (2002) Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ 9:237–245
271. Sureau A, Saulière J, Expert-Bezançon A, Marie J (2011) CELF and PTB proteins modulate the inclusion of the β-tropomyosin exon 6B during myogenic differentiation. Exp Cell Res 317:94–106
272. Sveen A, Kilpinen S, Ruusulehto A et al (2016) Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene 35:2413–2427
273. Tollervey JR, Wang Z, Hortobagyi T et al (2011) Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res 21:1572–1582
274. Topp JD, Jackson J, Melton AA, Lynch KW (2008) A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4. RNA 14:2038–2049
275. Traunmüller L, Gomez AM, Nguyen T-M, Scheiffele P (2016) Control of neuronal synapse specification by a highly dedicated alternative splicing program. Science 352:982–986
276. Treutlein B, Gokce O, Quake SR, Südhof TC (2014) Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing. Proc Natl Acad Sci USA 111:E1291–E1299
277. Trowbridge IS, Thomas ML (1994) CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 12:85–116
278. Tsai YS, Dominguez D, Gomez SM, Wang Z (2015) Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors. Oncotarget 6:6825–6839
279. Tucker P, Liu C, Mushinski J, Blattner F (1980) Mouse immunoglobulin D: messenger RNA and genomic DNA sequences. Science 209:1353–1360
280. Turner CA Jr, Mack DH, Davis MM (1994) Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77:297–306
281. Ule J, Ule A, Spencer J et al (2005) Nova regulates brain-specific splicing to shape the synapse. Nat Genet 37:844–852
282. Ule J, Jernej U, Darnell RB (2006) RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr Opin Neurobiol 16:102–110
283. van der Merwe PA, Bodian DL, Daenke S et al (1997) CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med 185:393–403
284. Venables JP, Elliott DJ, Makarova OV et al (2000) RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing. Hum Mol Genet 9:685–694
285. Venables JP, Dalgliesh C, Paronetto MP et al (2004) SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasome. Hum Mol Genet 13:1525–1534
286. Ver Heyen M, Heymans S, Antoons G et al (2001) Replacement of the muscle-specific sarcoplasmic reticulum Ca(2 +)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart. Circ Res 89:838–846
287. Vernet C, Artzt K (1997) STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet 13:479–484
288. Vuong CK, Black DL, Zheng S (2016) The neurogenetics of alternative splicing. Nat Rev Neurosci 17:265–281
289. Wagner SD, Berglund JA (2014) Alternative pre-mRNA splicing. Methods Mol Biol 1126:45–54
290. Walke DW, Morgan JI (2000) A comparison of the expression and properties of Apaf-1 and Apaf-1L11. Brain Res 886:73–81
291. Wang J, Manley JL (1995) Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1:335–346
292. Wang ET, Sandberg R, Luo S et al (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470–476
293. Wang Y, Chen D, Qian H et al (2014) The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. Cancer Cell 26:374–389
294. Wang ET, Ward AJ, Cherone JM et al (2015a) Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins. Genome Res 25:858–871
295. Wang F, Pan J, Liu Y et al (2015b) Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc Natl Acad Sci USA 112:4743–4748
296. Wang H-Y, Hsieh P-F, Huang D-F et al (2015c) RBFOX3/NeuN is required for hippocampal circuit balance and function. Sci Rep 5:17383
297. Wang H, Chen Y, Li X et al (2016) Genome-wide analysis of alternative splicing during human heart development. Sci Rep 6:35520
298. Ward AJ, Cooper TA (2009) The pathobiology of splicing. J Pathol. doi:10.1002/path.2649
299. Warf MB, Diegel JV, von Hippel PH, Berglund JA (2009) The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing. Proc Natl Acad Sci USA 106:9203–9208
300. Webb TR, Joyner AS, Potter PM (2013) The development and application of small molecule modulators of SF3b as therapeutic agents for cancer. Drug Discov Today 18:43–49
301. Wei C, Qiu J, Zhou Y et al (2015) Repression of the central splicing regulator RBFox2 Is functionally linked to pressure overload-induced heart failure. Cell Rep. doi:10.1016/j.celrep.2015.02.013
302. Westermann AJ, Gorski SA, Vogel J (2012) Dual RNA-seq of pathogen and host. Nat Rev Microbiol 10:618–630
303. Westermann AJ, Förstner KU, Amman F et al (2016) Dual RNA-seq unveils noncoding RNA functions in host–pathogen interactions. Nature 529:496–501
304. Weyn-Vanhentenryck SM, Aldo M, Qinghong Y et al (2014) HITS-CLIP and integrative modeling define the rbfox splicing-regulatory network linked to brain development and autism. Cell Rep 6:1139–1152
305. Wongpalee SP, Sharma S (2014) The pre-mRNA splicing reaction. Methods Mol Biol 1126:3–12
306. Woolard J, Vousden W, Moss SJ et al (2011) Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chem Sci 2011:273–278
307. Xia W, Yan Cheng C (2005) TGF-β3 regulates anchoring junction dynamics in the seminiferous epithelium of the rat testis via the Ras/ERK signaling pathway: an in vivo study. Dev Biol 280:321–343
308. Xu Z, Weiss A (2002) Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat Immunol 3:764–771
309. Xu J, Fang Y, Qin J et al (2016) A transcriptomic landscape of HPV16 E6-regulated gene expression and splicing events. FEBS Lett. doi:10.1002/1873-3468.12486
310. Xue Y, Ouyang K, Huang J et al (2013) Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. Cell 152:82–96
311. Yang J, Hung L-H, Licht T et al (2014) RBM24 is a major regulator of muscle-specific alternative splicing. Dev Cell 31:87–99
312. Yano M, Hayakawa-Yano Y, Mele A, Darnell RB (2010) Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling. Neuron 66:848–858
313. Yeo G, Holste D, Kreiman G, Burge CB (2004) Variation in alternative splicing across human tissues. Genome Biol 5:R74
314. Yong H, Zhu H, Zhang S et al (2016) Prognostic value of decreased expression of RBM4 in human gastric cancer. Sci Rep 6:28222
315. Young LS, Arrand JR, Murray PG (2011) EBV gene expression and regulation. In: Arvin A, Campadelli-Fiume G, Mocarski E et al (eds) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge
316. Zaghlool A, Ameur A, Cavelier L et al (2014) Splicing in the human brain. Int Rev Neurobiol 116:95–125
317. Zahid M, Robbins PD (2015) Cell-type specific penetrating peptides: therapeutic promises and challenges. Molecules 20:13055–13070
318. Zhang Y, Fear DJ, Willis-Owen SAG et al (2016) Global gene regulation during activation of immunoglobulin class switching in human B cells. Sci Rep 6:37988
319. Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6:730–755
320. Zheng S, Gray EE, Chawla G et al (2012) PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. Nat Neurosci 15(381–8):S1
321. Zhong W, Jiang MM, Schonemann MD et al (2000) Mouse numb is an essential gene involved in cortical neurogenesis. Proc Natl Acad Sci USA 97:6844–6849
322. Zhu C, Chen Z, Guo W (2016) Pre-mRNA mis-splicing of sarcomeric genes in heart failure. Biochim Biophys Acta. doi:10.1016/j.bbadis.2016.11.008